Novartis Contract Manufacturing is a fully integrated CDMO offering end-to-end manufacturing solutions for mammalian, microbial, advanced therapies (pDNA, mRNA, siRNA, autologous cell therapies, viral vectors), oligonucleotides, drug product, device assembly and packaging to meet our clients clinical and commercial supply needs. With state-of-the-art facilities across USA, Europe and Singapore, our manufacturing capabilities include:

• Mammalian: up to 13,000L scale
• Microbial: up to 13,000L scale
• Plasmid DNA: up to 1,300L scale
• mRNA: up to 150L scale
• Viral Vectors: adherent up to 500 m2 and suspension up to 500L
• Autologous Cell Therapy
• Fill and Finish: Vials (liquid, lyophilized), Pre-Filled Syringe, Droptainers and more
• Autoinjector device assembly
• Autologous Cell Therapy